Allotment of 90,000 Equity Shares on conversion of Warrants issued on Preferential basis.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has allotted 90,000 equity shares of face value Rs. 10 each at an issue price of Rs. 45 per share (including a premium of Rs. 35) following the conversion of warrants issued on a preferential basis. The shares have been allotted to Kompella Lopa Mudra, a member of the Promoter Group, against receipt of Rs. 30.37 lakh as 75% of the issue price. As a result, the company's total issued and subscribed share capital has risen to Rs. 22.19 crore, comprising 2,21,90,628 equity shares.
This is a small, incremental capital addition from a promoter-group warrant conversion, which strengthens the promoter's stake and brings in modest fresh funds, but is unlikely to materially impact the stock price given the tiny size of the allotment.